BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3857404)

  • 1. NHL-30.5: a monoclonal antibody reactive with an acute myeloid leukemia (AML)-associated antigen.
    Askew DS; Eaves AC; Takei F
    Leuk Res; 1985; 9(1):135-45. PubMed ID: 3857404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody-producing human-human hybridomas. III. Derivation and characterization of two antibodies with specificity for human myeloid cells.
    Andreasen RB; Olsson L
    J Immunol; 1986 Aug; 137(3):1083-90. PubMed ID: 3459756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of myeloid differentiation antigens on normal and malignant myeloid cells.
    Griffin JD; Ritz J; Nadler LM; Schlossman SF
    J Clin Invest; 1981 Oct; 68(4):932-41. PubMed ID: 6945311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human myeloid differentiation antigens identified by monoclonal antibodies: expression on leukemic cells.
    Bradstock KF; Favaloro EJ; Kabral A; Kerr A; Hughes WG; Berndt MC; Musgrove E
    Pathology; 1985 Jul; 17(3):392-9. PubMed ID: 3865147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
    Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
    Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A monoclonal antibody with reaction spectrum covering acute leukemia and T-lineage cells.
    Nogiwa E; Tamaki K; Omine M; Maekawa T
    Leuk Res; 1988; 12(3):249-56. PubMed ID: 3259278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restricted expression of a new acute myelogenous leukemia-associated antigen (NHL-30.5) on normal hemopoietic progenitor cells.
    Askew DS; Eaves AC; Eaves CJ; Takei F
    Blood; 1986 Apr; 67(4):1098-102. PubMed ID: 3456804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of My23, a myeloid cell-derived antigen reactive with the monoclonal antibody AML-2-23.
    Maliszewski CR; Ball ED; Graziano RF; Fanger MW
    J Immunol; 1985 Sep; 135(3):1929-36. PubMed ID: 3894519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of the 124-kd antigen defined by monoclonal antibody AML-1-99 on normal and leukemic myeloid cells.
    Howell AL; Miller R; Keefe KA; McIntyre OR; Stockner M; Sullivan R; Hibbert SR; Noelle RJ; Ball ED
    Exp Hematol; 1988 Mar; 16(3):176-83. PubMed ID: 3422192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells.
    Griffin JD; Linch D; Sabbath K; Larcom P; Schlossman SF
    Leuk Res; 1984; 8(4):521-34. PubMed ID: 6590930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hemopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells.
    Bühring HJ; Ullrich A; Schaudt K; Müller CA; Busch FW
    Leukemia; 1991 Oct; 5(10):854-60. PubMed ID: 1720490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
    Ball ED; Kadushin JM; Schacter B; Fanger MW
    J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies against human myelomonocytic cells: detection of certain lineage-specific antigens on CFU-GM progenitor cells.
    Takaishi M; Fu SM
    J Immunol; 1985 Aug; 135(2):1523-9. PubMed ID: 2409154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of minimal residual disease in acute myeloid leukemia.
    Gerhartz HH; Schmetzer H
    Leukemia; 1990 Jul; 4(7):508-16. PubMed ID: 1695705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies reactive with human myeloid leukaemia cells.
    Ball ED; Fanger MW
    Clin Exp Immunol; 1982 Jun; 48(3):655-65. PubMed ID: 6956470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of heteroantisera to human acute leukemia-associated antigens.
    Baker MA; Ramachandar K; Taub RN
    J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody against a unique antigen on human acute promyelocytic leukemia cell line (HL-60).
    Aota F; Chang D; Hill NO; Khan A
    Exp Hematol; 1982 Nov; 10(10):835-43. PubMed ID: 6759147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies reactive with acute myelogenous leukemia cells.
    Linker-Israeli M; Billing RJ; Foon KA; Terasaki PI
    J Immunol; 1981 Dec; 127(6):2473-7. PubMed ID: 7028873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restricted expression of an early myeloid and monocytic cell surface antigen defined by monoclonal antibody M195.
    Tanimoto M; Scheinberg DA; Cordon-Cardo C; Huie D; Clarkson BD; Old LJ
    Leukemia; 1989 May; 3(5):339-48. PubMed ID: 2716349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.